Posts by: Ana Pamplona, PhD

Ana Pamplona, PhD

Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.

July 8, 2015November 5, 2015

Damage To Telomeres Found To Cause Idiopathic Pulmonary Fibrosis in Mice

Idiopathic Pulmonary Fibrosis, News

Researchers at the Spanish National Cancer Centre and Complutense University of Madrid in Spain recently revealed that telomeres, structures that protect chromosomes, are associated with the genesis of idiopathic pulmonary fibrosis. ... Read more

July 6, 2015November 9, 2015

Interruption of Inhaled Corticosteroid Therapy in COPD Can Reduce Risk of Pneumonia

COPD, News

Researchers from McGill University in Canada showed that interruption of inhaled corticosteroid therapy in Chronic Obstructive Pulmonary Disease may lead to significant reduction in the risk of serious pneumonia. The ... Read more

July 2, 2015November 6, 2015

High Airborne Endotoxin Levels in Inner-city Classrooms Found To Lead to Increased Asthma Symptoms

Asthma, News

According to a new study, children living in urban areas with asthma are at risk of suffering additional asthma symptoms because of being exposed to high airborne endotoxin levels at school. ... Read more

June 12, 2015November 9, 2015

Gastroesophageal Reflux May Be a Potentially Reversible Cause of Bronchiolitis Obliterans Organizing Pneumonia

COPD, News

A recent study revealed for the first time the rare bronchiolitis obliterans organizing pneumonia caused by gastroesophageal reflux in pediatric patients. The study, entitled “Bronchiolitis Obliterans Organizing Pneumonia Due to Gastroesophageal Reflux,” was published in the journal Pediatrics ... Read more

June 3, 2015November 5, 2015

Pentoxifylline Appears to Prevent Lung Fibrosis in Experimental Chronic Pulmonary Paracoccidioidomycosis

Idiopathic Pulmonary Fibrosis, News

A new study on an experimental model of pulmonary paracoccidioidomycosis induced by the fungus Paracoccidioides brasiliensis (Pb) showed that pentoxifylline (PTX) therapy administered at an “early” stage of granulomatous inflammation ... Read more

May 28, 2015May 28, 2015

BinaxNOW and UAD Assays Tested in Lower Respiratory tract iInfection Study

News, Pneumonia

A new study on lower respiratory tract infections recently tested the BinaxNOW® and Urine Antigen Detection (UAD) assays to detect a common antigen from all pneumococcal strains and the 13 pneumococcal serotypes present in ... Read more

May 13, 2015May 13, 2015

Lower Doses of Prophylactic Antibody Found to Protect Against Respiratory Syncytial Virus Infection

Bronchiolitis, News

Researchers from the Yale School of Public Health shed new light on the factors that induced seasonal variations for Pneumococcal bacteria provided information that will help to understand and predict ... Read more

May 4, 2015November 5, 2015

Streptococcus Pneumoniae Infection Does Not Lead to Clinical Aggravation in Adult CF Patients

Cystic Fibrosis, News

A study entitled “Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study” was published in the BMC Pulmonary Medicine by Christina ... Read more

April 30, 2015November 5, 2015

Yale Researchers Effectively Correct Cystic Fibrosis Gene Mutation in Mice

Cystic Fibrosis

A research team from Yale University developed a new strategy to correct the most frequent mutation that causes cystic fibrosis. The study entitled “Nanoparticles that deliver triplex-forming peptide nucleic acid ... Read more

April 23, 2015November 5, 2015

Two New Potent DF508-CFTR Correctors Offer Potential to Treat Cystic Fibrosis

Cystic Fibrosis, News

An international group of researchers led by Aleksander Edelman from Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes) discovered two novel compounds that can target the genetic mutation that leads ... Read more